Preeclampsia | Norton Healthcare

Indication: Preeclampsia

Antithrombin III (AT) Activity in Women with Severe Preeclampsia (PE) or Superimposed PE prior to 31 weeks

Sub-indication: Preeclampsia

Study Type: Specimen Study

Principal Investigator: Helen How, M.D.
Maternal Fetal Medicine

Sponsor: Sponsor: University of Texas Health Science Center at Houst

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.